4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-20-061593
Chief Operating Officer sold 14,500 shares at an average $44.74 ($648,688)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nabulsi Azmi Chief Operating Officer | 2020-12-01 | Sale | −5,370 | $43.99 | $236,226 | 847,330 | I |
| Nabulsi Azmi Chief Operating Officer | 2020-12-01 | Sale | −1,828 | $44.83 | $81,949 | 845,502 | I |
| Nabulsi Azmi Chief Operating Officer | 2020-12-02 | Sale | −4,307 | $45.05 | $194,030 | 841,195 | I |
| Nabulsi Azmi Chief Operating Officer | 2020-12-02 | Sale | −2,995 | $45.57 | $136,482 | 838,200 | I |
| Open-market sales · 14,500 sh · avg $44.74 · $648,688 | |||||||
Loading xslF345X03/doc4.xml…